Skip to content

comparison of the effect of cinnamon and vitex oral capsules on sexual function in postmenopausal women

comparison of the effect of cinnamon and vitex oral capsules on sexual function in postmenopausal women coverd by selected health centers affiliated to shahid beheshti university of medical sciences in 2019

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200504047299N1
Enrollment
105
Registered
2020-07-08
Start date
2020-01-29
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

?????? ?????? ????. Sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: The intervention group is menopausal women, which will be divided into two groups: oral cinnamon capsules (400 mg) and vitex-agnus capsules (400 mg). The capsules will be provided at

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Be Iranian. 2. Have at least literacy. 3. Do not have speech, hearing or mental disorders that prevent communication with the researcher. 4. It's been at least a year since they stopped menstruating. 5. Have a married life with her spouse. 6. There is no inclination or obligation to use hormone replacement therapy. 7. As menopausal woman sated, do not use any chemical or herbal remedies to treat her problem. 8. Have sexual activity. 9. A postmenopausal wife does not have a sexual problem. 10. They have not undergone hysterectomy and ovariectomy, cystocele, rectocele, and mastectomy. 11. Menopausal women and their spouses do not have a known mental illness. 12. Not addicted to cigarettes or drugs. 13. He has not recently used antidepressants drugs. 14. Have no history of known chronic diseases such as high blood pressure, diabetes, asthma, weaken the immune system, etc. 15. Has no history of allergy to medicinal plants. 16. Do not use herbal teas during medication. 17. Age between 45 and 65 years

Exclusion criteria

Exclusion criteria: 1. Possible sensitivity to capsules 2. Do not take the capsule for a week or more 3. Lack of desire to continue treatment

Design outcomes

Primary

MeasureTime frame
Sexual dysfunction according to the FSFI questionnaire. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: FSFI questionnaire.

Secondary

MeasureTime frame
Sexual desire. Timepoint: Before intervention, 2 month after intervention, 3 moth after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Sexual satisfaction. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Orgasm. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Arousal. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Lubrication. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.;Pain during intercourse. Timepoint: Before intervention, 2 month after intervention, 3 month after intervention. Method of measurement: The Female Sexual Function Index (FSFI) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTanya Koliji

Shahid Beheshti University of Medical Sciences

tanipaezan.koliji@gmail.com+98 21 6652 0143

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026